Riskpilot← Back to searchSign inGet full accessHELICASE BIOSCIENCE AS
ASActiveOrg 930046949Akersbakken 37A, 0172 OsloOther software publishing · NACE 5829Est. 20220 employees
Revenue 2024
NOK 50K
EBITDA margin
96.6%
Equity ratio
87.1%
Financial strength
Net profit 2024
NOK 39K
0 employees
| Revenue | NOK 50K | — |
| EBITDA | NOK 48K | — |
| Net profit | NOK 39K | — |
| Total assets | NOK 73K | +198% |
| Equity | NOK 63K | +160% |
| Employees | 0 | — |
Legal name
HELICASE BIOSCIENCE AS
Org number
930046949
Legal form
Aksjeselskap
NACE code
5829 · Other software publishing
Founded
8. november 2022
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Utgivelse av annen programvare, tjenester tilknyttet informasjonsteknologi inkludert konsulentvirksomhet, forskning og utviklingsarbeid innen bioteknologi, teknisk konsulentvirksomhet, annen undervisning, tjenester tilknyttet undervisning og annet som naturlig faller sammen med dette.
Address
Akersbakken 37A, 0172 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 |
|---|---|---|
| Revenue | 0 | 50 |
| Staff expenses | −0 | −0 |
| EBITDA | 0 | 48 |
| Depreciation & amort. | −0 | −0 |
| EBIT | 0 | 48 |
| Net financials | 0 | 0 |
| Profit before tax | 0 | 48 |
| Tax | −0 | 9 |
| Net profit | 0 | 39 |
| Item | 2023 | 2024 |
|---|---|---|
| Total assets | 24 | 73 |
| Equity | 24 | 63 |
| Long-term debt | 0 | 0 |
| Short-term debt | 0 | 9 |
| Total debt | 0 | 9 |
EBITDA margin
96.6%
This company
15.8%
Market median
+511% vs market
20232024
Equity ratio
87.1%
This company
38.2%
Market median
+128% vs market
20232024
Return on equity
61.5%
This company
18.4%
Market median
+234% vs market
20232024
Net profit margin
77.8%
This company
8.1%
Market median
+860% vs market
20232024
Asset turnover
0.69×
This company
1.12×
Market median
-38% vs market
20232024
Debt / equity
0.15×
This company
0.62×
Market median
+76% vs market
20232024
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (6) | ||
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 14% | 14% | 2022 | |
| Individual | 14% | 14% | 2022 | |
| Individual | 14% | 14% | 2022 | |
| Individual | 2.5% | 2.5% | 2022 | |
| Individual | 2.5% | 2.5% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of HELICASE BIOSCIENCE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jørgen Sikkeland | Board of Directors | 0 companies |
| Håkon Ege | Board of Directors | 0 companies |
| Omer Faruk Kuzu | Board of Directors | 0 companies |
| Halil Afsar | Board of Directors | 0 companies |
| Nicklas Pihlstrøm | Board of Directors | 0 companies |
| Max Myklagard | Chairman | 0 companies |